This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Application of Path Analysis to Treatment Studies

Donald F. Klein, MD; Donald C. Ross, PhD; Patricia Cohen, PhD

Arch Gen Psychiatry. 1987;44(4):377-385.

Abstract
• We explored a causal sequence between panic and avoidance to provide recommendations for psychotherapy, pharmacotherapy, and their combination in treating agoraphobia. We produced a two-way ([imipramine hydrochloride vs placebo] by [office-based behavioral therapy vs in vivo exposure]) design by amalgamating two studies. We assessed agoraphobic patients for panic and avoidance at these time points: baseline (week 0), midcourse (week 13), and termination (week 26). The causal sequence model was tested by path analysis. Imipramine was superior to placebo in lowering panic and avoidance at both postbaseline time points. Exposure was superior to office-based treatment in lowering avoidance only at week 13. Exposure appeared to produce quicker improvement of avoidance than office-based therapy, but relapse occurred if this improvement was not supported by medication. Exposure did not benefit panic. We believe patients should be informed that imipramine is superior to exposure in inducing a panic-free state. Exposure without imipramine is of benefit only in reducing avoidance, but adding imipramine to exposure is necessary for panic control and substantially improves exposure and exposure maintenance.

Author Affiliations
From the Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York.

Footnotes
Accepted for publication Oct 13, 1986.

Reprint requests to New York State Psychiatric Institute, 722 W 168th St, New York, NY 10032 (Dr Klein).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Increased Anxiety During Anticipation of Unpredictable But Not Predictable Aversive Stimuli as a Psychophysiologic Marker of Panic Disorder
Grillon et al.
Am. J. Psychiatry 2008;165:898-904.
ABSTRACT | FULL TEXT  

An Investigation of Anxious Thought in Patients With Dsm-Iv Agoraphobia / Panic Disorder: Rationale and Design
Compton
J Am Psychoanal Assoc 1998;46:691-721.
ABSTRACT  

Commentary on 'Psychology and pharmacology in the treatment of anxiety disorders: co-operation or confrontation?'
Klein
J Psychopharmacol 1991;5:299-300.
 

Risk Factors for the Onset of Diagnostic Interview Schedule/DSM-III Agoraphobia in a Prospective, Population-Based Study
Eaton and Keyl
Arch Gen Psychiatry 1990;47:819-824.
ABSTRACT  

Drug Therapy for Agoraphobia
Scott et al.
Arch Gen Psychiatry 1988;45:387-387.
ABSTRACT  

The Cause and Treatment of Agoraphobia
Lelliott and Marks
Arch Gen Psychiatry 1988;45:388-389.
ABSTRACT  

Drug Therapy for Agoraphobia-Reply
Klein
Arch Gen Psychiatry 1988;45:387-388.
ABSTRACT